6.2.7: 7. Hurthle Cell Carcinoma

Atlas of Otolaryngology, Head and Neck Operative Surgery · LibreTexts

0%

Contents

    Text

    Size
    100%
    Theme
    Typeface
    Line length
    Spacing

    Read aloud

    How

    Speed: 1×
    Light up
    Highlight

    Symbols: Mulberry Symbols, © 2018–2026 Steve Lee, CC BY-SA 4.0 (licence, the set), the site's own copies.

    From LibreTexts, under CC BY-NC 3.0, as the source states it; its equations are written in TeX, which the PDF shows typeset. This page at LibreTexts.

    6.2.7: 7. Hurthle Cell Carcinoma

    Click on the clinical scenario that reflects the therapy available to your patient. This will transfer you to a resource appropriate management pathway.

    Scenarios 1 2 3 4 5 6 7 8
    Available treatment
    Thyroid monitoring/replacement X X X X Unavailable or
    poor follow-up
    Ca++ monitoring/replacement X X X X
    Radioactive iodine therapy X X X X

    This page titled 6.2.7: 7. Hurthle Cell Carcinoma was last modified on Sat, 11 Dec 2021 02:15:46 GMT and is shared under a CC BY-NC 3.0 license and was authored, remixed, and/or curated by Open Access Atlas of Otolaryngology, Head, and Neck Operative Surgery.